Skip to content

Platelet rich plasma combined with negative pressure wound healing in patients with spinal cord injury: A randomized controlled study

Platelet rich plasma combined with negative pressure wound healing in patients with spinal cord injury:A randomized controlled study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062162
Enrollment
Unknown
Registered
2022-07-26
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound treatment

Interventions

control group:negative pressure wounds treatment
Experimental group:Platelet-rich plasma + negative pressure wound treatment

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients with spinal cord injury; 2.SCI grade (ASIA grade) is grade A or B patient; 3.Age greater than 20 years; 4.Patients with no trend of wound healing after 1 month of treatment and no contraindications of negative pressure wound treatment after evaluation by wound experts.

Exclusion criteria

Exclusion criteria: 1.Necrotic tissue scabs; 2.Untreated osteomyelitis; 3.non-tubular and non-detectable fistulas; 4.There is a malignant tumor at the wound; 5.Sites exposing blood vessels, nerves, anastomosis sites, bone tissues and tendons; 6.Obvious abnormalities in coagulation function; 7.Severe hypoproteinemia; 8.Severe shock is not corrected or there are other serious fatal injuries; 9.Patients with active bleeding on the wound; 10.Vascular diseases: no blood supply to local tissues or venous thrombosis; 11.Patients whose surface wounds cannot be closed with negative pressure drainage films; 12.Patients with chest or cranial wounds; 13.Those who are allergic to polymer materials; 14.Patients with incomplete wound debridement or still having a large amount of necrotic substances.

Design outcomes

Primary

MeasureTime frame
Wound healing condition;

Secondary

MeasureTime frame
Detection of serum inflammatory indicators;Bacterial culture;Scarring condition after the wound is completely healed;Incidence of adverse reactions;

Countries

China

Contacts

Public ContactHongying Jiang
b.julia7755@163.com18980606073

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026